2008
DOI: 10.2147/ijn.s2714
|View full text |Cite
|
Sign up to set email alerts
|

Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells

Abstract: Drug resistance is a primary hindrance for effi ciency of chemotherapy. To investigate whether Fe 3 O 4 -magnetic nanoparticles (Fe 3 O 4 -MNPs) loaded with adriamycin (ADM) and tetrandrine (Tet) would play a synergetic reverse role in multidrug resistant cell, we prepared the drug-loaded nanoparticles by mechanical absorption polymerization to act with K562 and one of its resistant cell line K562/A02. The survival of cells which were cultured with these conjugates for 48 h was observed by MTT assay. Using cel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(3 citation statements)
references
References 26 publications
1
2
0
Order By: Relevance
“…Co-administration of Doxorubicin and magnetite nanoparticles in presence of magnetic field showed cytotoxic effects against breast cancer cell lines MDA-MB-468 with greater than 80% cell death in hyperthermia combination than with Doxorubicin alone (Sadeghi-Aliabadi et al, 2013 ). Similar drug resistance inhibitory effect of magnetite nanoparticles loaded with Doxorubicin and Tetrandrine against K562 leukemia cells have been reported by Wang et al ( 2007 ), Chen et al ( 2008 ). Significant reduction in transcriptions of Mdr-1 and Bcl-2 gene and increased expressions of Bax and caspase-3 in K562-n and K562-n/VCR cells in-vivo in nude mice revealed the potential of Daunorubicin magnetic nanoparticles to overcome multi-drug resistance (Chen et al, 2009b ).…”
Section: Nanocarriers As Potential Drug Delivery Systems In Cancer Thsupporting
confidence: 86%
See 1 more Smart Citation
“…Co-administration of Doxorubicin and magnetite nanoparticles in presence of magnetic field showed cytotoxic effects against breast cancer cell lines MDA-MB-468 with greater than 80% cell death in hyperthermia combination than with Doxorubicin alone (Sadeghi-Aliabadi et al, 2013 ). Similar drug resistance inhibitory effect of magnetite nanoparticles loaded with Doxorubicin and Tetrandrine against K562 leukemia cells have been reported by Wang et al ( 2007 ), Chen et al ( 2008 ). Significant reduction in transcriptions of Mdr-1 and Bcl-2 gene and increased expressions of Bax and caspase-3 in K562-n and K562-n/VCR cells in-vivo in nude mice revealed the potential of Daunorubicin magnetic nanoparticles to overcome multi-drug resistance (Chen et al, 2009b ).…”
Section: Nanocarriers As Potential Drug Delivery Systems In Cancer Thsupporting
confidence: 86%
“…Cisplatin magnetic nanoparticles enhanced inhibition of A549 cells and cisplatin-resistant A549 cells in MDR lung cancer cells, lowered the levels of MRP1, lung resistance-related protein, Akt and Bad pathways and increased the levels of caspase-3 genes and proteins (Li et al, 2013a ). Single drug Tetrandrine loaded magnetic nanoparticles revealed a 100-fold lowering in mdrl mRNA level but no reduction in total P-gp content while magnetic nanoparticles loaded with Adriamycin and Tetrandrine synergistically reversed multidrug resistant in K562/A02 resistant cell lines (Chen et al, 2008 ). Heparin coated Doxorubicin super-paramagnetic iron oxide nanoparticles promoted apoptosis due to regulation of anti-apoptotic genes including caspase-3, bax, bcl-2 and surviving in human ovarian cancer cell lines A2780 (Javid et al, 2011 ).…”
Section: Nanocarriers As Potential Drug Delivery Systems In Cancer Thmentioning
confidence: 99%
“…Such limitations were addressed through the development of various targeted delivery systems involving the conjugation of drug to various biomaterials such as biodegradable polymers made up of polyethylenimine [4] , PLGA [5] , modified liposomes [6] – [9] , peptides and proteins [10] , [11] . Recent developments include introduction of nanoparticles consisting of poly (ethyl amine)-b-poly(n-isopropyl acetylated derivative), nanoparticles of Fe 3 O 4 [12] , [13] , polymeric dendrimers [14] , [15] , poly hydrogen acylated nanoparticles, core-shell co-polymer nanoparticles [16] [18] , DOTA–NHS-ester [19] , PEG-PEL nanoparticles [20] . Though these materials are biocompatible, they lack target-specificity besides their high energy-demanding for degradation of biomaterial in cells and tissues.…”
Section: Introductionmentioning
confidence: 99%